JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

6.12: Component recall and traceability

There must be a documented system available in each Blood Establishment whereby adverse effects caused by the administration of any component, or the identification of a component quality problem, can enable the recall, if appropriate, of all unused components derived from that donation or all donations which are a constituent of a component pool. Similarly, there must be a documented system in each Blood Centre for the recall of any component or constituent of a component pool where reasonable grounds exist for believing it could cause adverse effects.

Any recall of a component should lead to a thorough investigation with a view to preventing a recurrence.

A system must be in place that ensures that any transfused (or discarded) blood component can be linked to the original donation and donor from which it was derived.7

 

Last updated 13/03/2024